35 results
Pediatric Vital Signs Reference PocketCard
#Diagnosis #Peds #Pediatric #VitalSigns #PocketCard #HeartRate #RespiratoryRate #Age #Normal #Nursing
Pediatric Vital ... Signs Reference ... Diagnosis #Peds #Pediatric ... RespiratoryRate #Age ... #Normal #Nursing
This table, along with our detailed references can be found online at http://www.pedscases.com/pediatric-vital-signsreference-chart .
For a more
with our detailed references ... our podcast on “Pediatric ... Diagnosis #Peds #Pediatric ... BloodPressure #Age ... #Normals #Nursing
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... + Warfarin) Reference ... #DOAC #Dosing #Oral
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
binders - quick reference ... agents since they are ... levels toward the normal ... Note not listed are ... Hyperphosphatemia #Dose #Dosing
Guideline 1 recommends that the highest risk infants — those with severe eczema and/or egg allergy
4-6 months of age ... around 6 months of age ... accordance with family preferences ... accordance with family preferences ... #pediatrics #eczema
Causes of Pediatric Wheezing - Differential Diagnosis Algorithm
CXR Abnormal:
 • Pulmonary Sequestration
 • Congenital Adenoid Cystic
Causes of Pediatric ... Differential Diagnosis Algorithm ... CXR Abnormal: ... Aspiration • GE ... #Causes #Peds #Pediatrics
NORMAL VITAL SIGNS - Reference Sheet for Healthcare Providers

#VITALSIGNS #NORMAL #Diagnosis #Ranges #Ages
NORMAL VITAL SIGNS ... - Reference Sheet ... #VITALSIGNS #NORMAL ... Diagnosis #Ranges #Ages
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Vasculitis Management Algorithm ... High-Dose Daily Oral ... Options in Order of Preference ... ACR2021 #Guidelines #algorithm
Treatment of Alcohol Use Disorder

Treatment options for AUD include psychosocial treatment and medications. Individualize based on
based on patient preference ... Individualize per patient preference ... liver disease or using ... settings where meds are ... Baclofen • None are
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... Suggested treatment algorithm ... bleeding risk during ... with patients’ preference ... DOAC, direct oral